- Hardcover: 504 pages
- Publisher: The Guilford Press; 1 edition (May 1, 1996)
- Language: English
- ISBN-10: 1572300671
- ISBN-13: 978-1572300675
- Product Dimensions: 9.5 x 6.5 x 1.3 inches
- Shipping Weight: 2 pounds (View shipping rates and policies)
- Average Customer Review: 5.0 out of 5 stars See all reviews (1 customer review)
- Amazon Best Sellers Rank: #9,491,975 in Books (See Top 100 in Books)
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your mobile phone number.
Challenges in Clinical Practice: Pharmacologic and Psychosocial Strategies 1st Edition
Use the Amazon App to scan ISBNs and compare prices.
"The book, Challenges in Clinical Practice, is a state-of-the-science text of the biopsychosocial model in action. It should be a 'must' text on the shelf of every mental health researcher and practitioner, and especially in the hands of every resident in psychiatry and graduate student in clinical psychology. It certainly will be used by me in teaching residents in my clinical classes." --Al. S. Fedoravicius, Ph.D., Chief, Psychology Service, VA Medical Center, Albuquerque; Depts of Psychology and Psychiatry, University of New Mexico
"Modern day mental health clinicians now have powerful empirically supported drug and psychosocial treatments in their armamentarium for the majority of mental disorders, and yet most clinicians are all too aware of the large number of treatment resistant patients who fail to benefit sufficiently from these interventions. Now, three of the leading clinicians and clinical scientists in the country from the Massachusetts General Hospital address the issue of treatment resistant patients, bringing to bear the latest information on this difficult issue. Particularly noteworthy is that these distinguished clinicians are accustomed to integrating drug and psychosocial treatments in clinical care in their setting. Therefore, clinicians everywhere confronting treatment-resistant patients can benefit from the newest integrative strategies for helping these individuals. This book should be on every clinician's shelf." --David H. Barlow, Ph.D., Professor and Director of Clinical Programs, Boston University
About the Author
Michael W. Otto, Ph.D. is currently the Director of the Cognitive-Behavior Therapy Program at the Massachusetts General Hospital and Assistant Professor of Psychology at Harvard Medical School.
Jerrold F. Rosenbaum, M.D., is Director of the Outpatient Psychiatry Division and Chief of the Clinical Psychopharmacology Unit at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.